Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
64 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
2 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
3 Recruiting ART and Inflammatory and Coagulation Biomarkers
Conditions: HIV (Human Immunodeficiency Virus);   AIDS (Acquired Immune Deficiency Syndrome);   Tuberculosis;   Non-communicable Diseases (NCD)
Intervention:
4 Recruiting Understanding the Role of Genes and Biomarkers in the Blood Clotting Process in Children With Acute Lung Injury
Condition: Respiratory Distress Syndrome, Adult
Intervention:
5 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
6 Recruiting Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
Conditions: Heart Failure;   Respiratory Failure
Intervention:
7 Recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
8 Recruiting Decitabine for High-Risk Sickle Cell Disease
Conditions: Neutropenia;   Sickle Cell Disease
Intervention: Drug: Decitabine
9 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
10 Not yet recruiting Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Condition: Thrombocytopenia
Interventions: Biological: CPP;   Biological: LSP
11 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily;   Drug: Atorvastatin 40 mg daily
12 Recruiting The Interaction of Social Factors With Air Pollution
Condition: Exposure to Environmental Pollution, Non-occupational
Interventions: Other: Clean Air;   Other: Ozone
13 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
14 Recruiting Personalized Medicine Decision-Making in a Virtual Clinical Setting
Conditions: Deep Vein Thrombosis;   Blood Clots
Intervention:
15 Recruiting Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
Conditions: Stroke;   Brain Infarction
Intervention: Drug: Eptifibatide
16 Unknown  Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Conditions: Sepsis;   Septicemia;   Sepsis Syndrome;   Shock, Septic;   Community Acquired Pneumonia
Intervention:
17 Recruiting Chronology of Occult and Gross Coagulopathy in Burn Patients
Condition: Thermal Burns
Intervention:
18 Recruiting Control of Major Bleeding After Trauma Study
Conditions: Trauma;   Hemorrhagic Shock
Interventions: Biological: Type AB plasma;   Drug: Crystalloid fluid (standard of care for resuscitation)
19 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
20 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years